| For: | Rusman RD, Akil F, Parewangi ML, Daud NA, Bachtiar R, Kusuma SH, Rifai A. Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention. World J Exp Med 2025; 15(4): 107316 [PMID: 41497693 DOI: 10.5493/wjem.v15.i4.107316] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i4/107316.htm |
| Number | Citing Articles |
| 1 |
Xinyue Hu, Xiaofang Yang, Zhou Zhu, Zhihong Yang, Pengyu Wang, Min Wu, Ning Zhang. Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1768784
|
| 2 |
Yeonsoo Kim, Seonghwan Hwang. Role of Sirtuin 6 in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Current Issues in Molecular Biology 2026; 48(5): 435 doi: 10.3390/cimb48050435
|
| 3 |
Resha Dermawansyah Rusman, Muhammad Luthfi Parewangi, Fardah Akil, Nu'man A S Daud, Rini R Bachtiar, Susanto Hendra Kusuma, Amelia Rifai, Akiko Syawalidhany Tahir. Carvedilol and nonselective-beta-blockers <i>vs</i> endoscopic ligation for prophylaxis of esophageal variceal hemorrhage in cirrhosis: Systematic review and meta-analysis. World Journal of Hepatology 2026; 18(5): 117049 doi: 10.4254/wjh.v18.i5.117049
|